Center-Authored Papers

Filters: Author is Novak, Richard M  [Clear All Filters]
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 
Young Adult
Koblin BA, Metch B, Novak RM, Morgan C, Lucy D, Dunbar D, Graham P, Swann E, Madenwald T, Escamilia G et al..  2013.  Feasibility of identifying a cohort of US women at high risk for HIV infection for HIV vaccine efficacy trials: longitudinal results of HVTN 906.. Journal of acquired immune deficiency syndromes (1999). 63(2):239-44. Abstract
Vaccines, DNA
Priddy FH, Brown D, Kublin J, Monahan K, Wright DP, Lalezari J, Santiago S, Marmor M, Lally M, Novak RM et al..  2008.  Safety and immunogenicity of a replication-incompetent adenovirus type 5 HIV-1 clade B gag/pol/nef vaccine in healthy adults.. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America. 46(11):1769-81. Abstract
Vaccine and Infectious Disease Institute
Priddy FH, Brown D, Kublin J, Monahan K, Wright DP, Lalezari J, Santiago S, Marmor M, Lally M, Novak RM et al..  2008.  Safety and immunogenicity of a replication-incompetent adenovirus type 5 HIV-1 clade B gag/pol/nef vaccine in healthy adults.. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America. 46(11):1769-81. Abstract
Vaccine and Infectious Disease Division
Hammer SM, Sobieszczyk ME, Janes H, Karuna ST, Mulligan MJ, Grove D, Koblin BA, Buchbinder SP, Keefer MC, Tomaras GD et al..  2013.  Efficacy Trial of a DNA/rAd5 HIV-1 Preventive Vaccine.. The New England journal of medicine. Abstract
Novak RM, Metch B, Buchbinder S, Cabello R, Donastorg Y, Figoroa J-P, Abdul-Jauwad H, Adbul-Jauwad H, Joseph P, Koenig E et al..  2013.  Risk behavior among women enrolled in a randomized controlled efficacy trial of an adenoviral vector vaccine to prevent HIV acquisition.. AIDS (London, England). 27(11):1763-70. Abstract
Koblin BA, Metch B, Novak RM, Morgan C, Lucy D, Dunbar D, Graham P, Swann E, Madenwald T, Escamilia G et al..  2013.  Feasibility of identifying a cohort of US women at high risk for HIV infection for HIV vaccine efficacy trials: longitudinal results of HVTN 906.. Journal of acquired immune deficiency syndromes (1999). 63(2):239-44. Abstract
McKinnon LR, Hughes SM, De Rosa SC, Martinson JA, Plants J, Brady KE, Gumbi PP, Adams DJ, Vojtech L, Galloway CG et al..  2014.  Optimizing viable leukocyte sampling from the female genital tract for clinical trials: an international multi-site study.. PloS one. 9(1):e85675. Abstract
Unsafe Sex
Koblin BA, Metch B, Novak RM, Morgan C, Lucy D, Dunbar D, Graham P, Swann E, Madenwald T, Escamilia G et al..  2013.  Feasibility of identifying a cohort of US women at high risk for HIV infection for HIV vaccine efficacy trials: longitudinal results of HVTN 906.. Journal of acquired immune deficiency syndromes (1999). 63(2):239-44. Abstract
United States
Koblin BA, Metch B, Novak RM, Morgan C, Lucy D, Dunbar D, Graham P, Swann E, Madenwald T, Escamilia G et al..  2013.  Feasibility of identifying a cohort of US women at high risk for HIV infection for HIV vaccine efficacy trials: longitudinal results of HVTN 906.. Journal of acquired immune deficiency syndromes (1999). 63(2):239-44. Abstract
Substance-Related Disorders
Novak RM, Metch B, Buchbinder S, Cabello R, Donastorg Y, Figoroa J-P, Abdul-Jauwad H, Adbul-Jauwad H, Joseph P, Koenig E et al..  2013.  Risk behavior among women enrolled in a randomized controlled efficacy trial of an adenoviral vector vaccine to prevent HIV acquisition.. AIDS (London, England). 27(11):1763-70. Abstract
South America
Novak RM, Metch B, Buchbinder S, Cabello R, Donastorg Y, Figoroa J-P, Abdul-Jauwad H, Adbul-Jauwad H, Joseph P, Koenig E et al..  2013.  Risk behavior among women enrolled in a randomized controlled efficacy trial of an adenoviral vector vaccine to prevent HIV acquisition.. AIDS (London, England). 27(11):1763-70. Abstract
Sexual Partners
Koblin BA, Metch B, Novak RM, Morgan C, Lucy D, Dunbar D, Graham P, Swann E, Madenwald T, Escamilia G et al..  2013.  Feasibility of identifying a cohort of US women at high risk for HIV infection for HIV vaccine efficacy trials: longitudinal results of HVTN 906.. Journal of acquired immune deficiency syndromes (1999). 63(2):239-44. Abstract
Sexual Behavior
Novak RM, Metch B, Buchbinder S, Cabello R, Donastorg Y, Figoroa J-P, Abdul-Jauwad H, Adbul-Jauwad H, Joseph P, Koenig E et al..  2013.  Risk behavior among women enrolled in a randomized controlled efficacy trial of an adenoviral vector vaccine to prevent HIV acquisition.. AIDS (London, England). 27(11):1763-70. Abstract
Safety
Priddy FH, Brown D, Kublin J, Monahan K, Wright DP, Lalezari J, Santiago S, Marmor M, Lally M, Novak RM et al..  2008.  Safety and immunogenicity of a replication-incompetent adenovirus type 5 HIV-1 clade B gag/pol/nef vaccine in healthy adults.. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America. 46(11):1769-81. Abstract
Risk-Taking
Novak RM, Metch B, Buchbinder S, Cabello R, Donastorg Y, Figoroa J-P, Abdul-Jauwad H, Adbul-Jauwad H, Joseph P, Koenig E et al..  2013.  Risk behavior among women enrolled in a randomized controlled efficacy trial of an adenoviral vector vaccine to prevent HIV acquisition.. AIDS (London, England). 27(11):1763-70. Abstract
Koblin BA, Metch B, Novak RM, Morgan C, Lucy D, Dunbar D, Graham P, Swann E, Madenwald T, Escamilia G et al..  2013.  Feasibility of identifying a cohort of US women at high risk for HIV infection for HIV vaccine efficacy trials: longitudinal results of HVTN 906.. Journal of acquired immune deficiency syndromes (1999). 63(2):239-44. Abstract
Questionnaires
Koblin BA, Metch B, Novak RM, Morgan C, Lucy D, Dunbar D, Graham P, Swann E, Madenwald T, Escamilia G et al..  2013.  Feasibility of identifying a cohort of US women at high risk for HIV infection for HIV vaccine efficacy trials: longitudinal results of HVTN 906.. Journal of acquired immune deficiency syndromes (1999). 63(2):239-44. Abstract
Public Health Sciences Division
Hammer SM, Sobieszczyk ME, Janes H, Karuna ST, Mulligan MJ, Grove D, Koblin BA, Buchbinder SP, Keefer MC, Tomaras GD et al..  2013.  Efficacy Trial of a DNA/rAd5 HIV-1 Preventive Vaccine.. The New England journal of medicine. Abstract
PREGNANCY
Novak RM, Metch B, Buchbinder S, Cabello R, Donastorg Y, Figoroa J-P, Abdul-Jauwad H, Adbul-Jauwad H, Joseph P, Koenig E et al..  2013.  Risk behavior among women enrolled in a randomized controlled efficacy trial of an adenoviral vector vaccine to prevent HIV acquisition.. AIDS (London, England). 27(11):1763-70. Abstract
Koblin BA, Metch B, Novak RM, Morgan C, Lucy D, Dunbar D, Graham P, Swann E, Madenwald T, Escamilia G et al..  2013.  Feasibility of identifying a cohort of US women at high risk for HIV infection for HIV vaccine efficacy trials: longitudinal results of HVTN 906.. Journal of acquired immune deficiency syndromes (1999). 63(2):239-44. Abstract
Placebos
Novak RM, Metch B, Buchbinder S, Cabello R, Donastorg Y, Figoroa J-P, Abdul-Jauwad H, Adbul-Jauwad H, Joseph P, Koenig E et al..  2013.  Risk behavior among women enrolled in a randomized controlled efficacy trial of an adenoviral vector vaccine to prevent HIV acquisition.. AIDS (London, England). 27(11):1763-70. Abstract
Patient Selection
Koblin BA, Metch B, Novak RM, Morgan C, Lucy D, Dunbar D, Graham P, Swann E, Madenwald T, Escamilia G et al..  2013.  Feasibility of identifying a cohort of US women at high risk for HIV infection for HIV vaccine efficacy trials: longitudinal results of HVTN 906.. Journal of acquired immune deficiency syndromes (1999). 63(2):239-44. Abstract
October 2013
Hammer SM, Sobieszczyk ME, Janes H, Karuna ST, Mulligan MJ, Grove D, Koblin BA, Buchbinder SP, Keefer MC, Tomaras GD et al..  2013.  Efficacy Trial of a DNA/rAd5 HIV-1 Preventive Vaccine.. The New England journal of medicine. Abstract
North America
Novak RM, Metch B, Buchbinder S, Cabello R, Donastorg Y, Figoroa J-P, Abdul-Jauwad H, Adbul-Jauwad H, Joseph P, Koenig E et al..  2013.  Risk behavior among women enrolled in a randomized controlled efficacy trial of an adenoviral vector vaccine to prevent HIV acquisition.. AIDS (London, England). 27(11):1763-70. Abstract
Middle Aged
Novak RM, Metch B, Buchbinder S, Cabello R, Donastorg Y, Figoroa J-P, Abdul-Jauwad H, Adbul-Jauwad H, Joseph P, Koenig E et al..  2013.  Risk behavior among women enrolled in a randomized controlled efficacy trial of an adenoviral vector vaccine to prevent HIV acquisition.. AIDS (London, England). 27(11):1763-70. Abstract